The effect of switching from calcineurin inhibitor to sirolimus on the incidence of skin cancers in kidney transplant recipients.
McQuillan
R F
RF
O'Seaghdha
C M
CM
Bagatto
A
A
Manusamy
M
M
Errakiah
N
N
Sinnott
C
C
O'Kelly
P
P
Murphy
G M
GM
Conlon
P J
PJ
D065095:Calcineurin Inhibitors; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation; D020123:Sirolimus / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000453:epidemiology*
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D020123:Sirolimus